Last updated: 2026-10-09 21:50:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Pulsenmore Ltd. (PLSM) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.87, with a market capitalization of $12.39M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.82 to $12.97. This page covers its latest market performance, valuation, price trends and company information.
$12.39M | |
$1.84 | |
$12.97 | |
$1.82 | |
$1.92 | |
15.97K | |
477.88K | |
-- | |
$12.97 | |
$1.82 | |
-- | |
-- |
Pulsenmore Ltd. (PLSM) is trading at $1.87 in after-hours trading as of 2026-10-09 21:25:00, down 2.60% ($0.05) from the regular-session close of $1.92.
After-hours trading shows how investors are pricing PLSM after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, Pulsenmore Ltd. (PLSM) moved from $2.22 to $1.87, representing a decline of 15.77% ($0.35).
The stock traded between $1.82 and $2.48 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 40.16 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.4%
PLSM is currently trading at $1.87, placing it 0.4% of the way from its 52-week low of $1.82 to its 52-week high of $12.97. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.
| Employees | 63 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Pulsenmore Ltd. (PLSM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.